Product Images Verquvo

This text appears to be a table presenting numerical values for different parameters such as age, weight, sex, race and ethnicity. The values seem to be categorized into different subgroups and are presented as point estimates and confidence intervals. The table also provides information on dose and body weight normalized AUC and dose and body weight normalized, after single dose administration. It appears to be a pharmacokinetic analysis of a drug called Vericiguat.*

This is a chart showing the Cumulative Incidence Rate over 36 months since Randomization for VERQUVO and Placebo treatments. The chart displays the Cumulative Incidence Rate on the y-axis, and the number of months since randomization on the x-axis. The number of subjects at risk is also shown.*

The text seems to be a combination of a table and data variables. It includes information about demographic variables such as gender, age, race, geographic region, and medical variables such as eGFR, NYHA class, use of Sacubitril/Valsartan. The table contains numerical values, percentages, and Hazard Ratio with their confidence interval. The purpose and context of the data are not available.*

Verquvo is a medication that comes in tablet form with 5 mg of vericiguat, which is dispensed to patients with a prescription. The accompanying Medication Guide should be given to each patient. The NDC code for this medication is 0006-5029-02. Additional text appears to contain unintelligible characters, making it difficult to discern the purpose of the medication or how it is used.*